Teva Gyogyszergyar Zartkoruen Mukodo Reszvenytarsasag

Assia Chemical Industries Ltd.

Teva Gyógyszergyár Zártkörún Müködö Részvénytársaság

Teva Gyógyszergyár Zárkörüen Müködö Részvénytársaság

Sandor Janos Molnar

Csaba Szabo

Tivadar Tamas

Janos Hajko

Judith Aronhime

Adrienne Kovacsne-Mezei

Viktor Gyollai

Csilla Nemethne Racz

Amihai Eisenstadt

Szabolcs Salyi

Erzsebet Meszaros Sos

Beáta Kosztya

Andrea Szilagyi

Zsuzsa Potarine Juhasz

Szabolcs Struba

Renata Kerti-Ferenczi

Nora Pasztor-Debreczeni

Zoltan Gabor Toth

Micahel Pinchasov

Kovacsne-Mezei; Adrienne

Processes for the preparation of Venetoclax and Venetoclax produced by the processes are disclosed. Intermediate compounds used in the processes are further disclosed including the compound of formula 5 

Solid state forms of Venetoclax and processes for preparation of Venetoclax

An amorphous pimecrolimus and processes for providing an amorphous pimecrolimus are provided.

Non-hygroscopic and powdery amorphous pimecrolimus

Provided are crystalline mycophenolate sodium forms and processes for their preparation.

Crystalline mycophenolate sodium

Provided is an impurity of mycophenolate mofetil, processes for its preparation and its use as a reference.

Mycophenolate mofetil impurity

A process for preparing ondansetron by transamination of an ondansetron structural analog that can be readily prepared conveniently by a Mannich reaction is provided. The process represents an improvement upon known procedures for making ondansetron by transamination because of its rapid rate, selectivity and the ease with which the product can be isolated from the reaction mixture.

Process for preparing 1,2,3,9-tetrahydro-9-methyl-3-[(2-methyl-1H-imidazol-1-YL)methyl]-4H-carbazol-4-one

Growing community of inventors

Debrecen, Hungary

Sandor Janos Molnar